Wietse Geens
cris.vub.be
0000-0002-2496-9209
Vrije Universiteit Brussel
19 papers found
Refreshing results…
From bleeding to diagnosis : unveiling a case of epithelioid hemangioendothelioma
Enhacing brain tumor border detection through navigated intraoperative ultrasound imaging
Health-related quality of life and neurocognitive functioning in patients with recurrent glioblastoma treated with intracerebral immune checkpoint inhibition
Data from ERK1/2 Phosphorylation Predicts Survival in Recurrent Glioblastoma Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy: A REMARK-guided Analysis
Supplementary Figure S2 from ERK1/2 Phosphorylation Predicts Survival in Recurrent Glioblastoma Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy: A REMARK-guided Analysis
Supplementary Figure S1 from ERK1/2 Phosphorylation Predicts Survival in Recurrent Glioblastoma Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy: A REMARK-guided Analysis
Supplementary Table S1 from ERK1/2 Phosphorylation Predicts Survival in Recurrent Glioblastoma Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy: A REMARK-guided Analysis
Supplementary Figure S3 from ERK1/2 Phosphorylation Predicts Survival in Recurrent Glioblastoma Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy: A REMARK-guided Analysis
ERK1/2 Phosphorylation Predicts Survival in Recurrent Glioblastoma Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy: A REMARK-guided Analysis
Neuro-oncological augmented reality planning for intracranial tumor resection
Probabilistic Tissue Mapping for Tumor Segmentation and Infiltration Detection of Glioma
A Phase I Clinical Trial on the Intracranial Administration of Increasing Doses of Ipilimumab Plus Fixed Dose Nivolumab in Patients With Recurrent Glioblastoma (Rgb)
GBM tumors are heterogeneous in their fatty acid metabolism and modulating fatty acid metabolism sensitizes cancer cells derived from recurring GBM tumors to temozolomide
Repeated intracranial administration of ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB): A multi-cohort adaptive phase I clinical trial
A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB).
Intra-Cranial Administration of Ctla-4 and Pd-1 Immune Checkpoint-Inhibiting Monoclonal Antibodies in Recurrent Glioblastoma Patients: A Multi-Cohort Adaptive Phase I Clinical Trial
Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: a phase I clinical trial
The Added Value of High Dose Spinal Cord Stimulation in Patients with Failed Back Surgery Syndrome after Conversion from Standard Spinal Cord Stimulation
Fourth ventricle papilloma and intractable cough
Missing publications? Search for publications with a matching author name.